Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionZurcher Kantonalbank (Zurich Cantonalbank)
Latest Disclosed Ownership37,560 shares
Latest Disclosed Value $ 1,115,908
Zurcher Kantonalbank (Zurich Cantonalbank) reports 21.64% increase in ownership of TVTX / Travere Therapeutics, Inc.

On May 15, 2026 - Zurcher Kantonalbank (Zurich Cantonalbank) filed a 13F-HR form disclosing ownership of 37,560 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $1,115,908 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 30,877 shares of Travere Therapeutics, Inc.. This represents a change in shares of 21.64% during the quarter. The current value of the position is $1,697,712 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 37,560 6,683 21.64 1,116 -5.43 0.0024
2026-01-27 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 30,877 5,344 20.93 1,180 93.28 0.0025
2025-11-14 2025-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 25,533 -195 -0.76 610 60.53 0.0014
2025-08-07 2025-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 25,728 2,772 12.08 381 -7.54 0.0009
2025-05-07 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 22,956 2,987 14.96 411 18.44 0.0012
2025-02-07 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 19,969 0 0.00 348 24.37 0.0010
2024-11-14 2024-09-30 13F/A-1 TRAVERE THERAPEUTICS COM 89422G107 19,969 3,458 20.94 279 106.67 0.0008
2024-11-08 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 19,969 3,458 279 0.0008
2024-07-29 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 16,511 0 0.00 136 6.30 0.0004
2024-04-25 2024-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 16,511 0 0.00 127 -14.19 0.0004
2024-01-30 2023-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 16,511 0 0.00 148 0.68 0.0006
2023-10-25 2023-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 16,511 4,007 32.05 148 -23.44 0.0007
2023-08-07 2023-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 12,504 193 1.57 192 -30.43 0.0008
2023-05-08 2023-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 12,311 2,879 30.52 277 39.39 0.0013
2023-02-01 2022-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 9,432 1,928 25.69 198 7.03 0.0011
2022-11-09 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 7,504 0 0.00 185 1.65 0.0011
2022-08-09 2022-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 7,504 -2,169 -22.42 182 -26.91 0.0011
2022-04-21 2022-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 9,673 -1,013 -9.48 249 -25.00 0.0012
2022-02-01 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 10,686 3,006 39.14 332 78.49 0.0016
2021-11-15 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 7,680 4 0.05 186 66.07 0.0010
2021-07-30 2021-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 7,676 89 1.17 112 -40.74 0.0006
2021-05-03 2021-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 7,587 -147 -1.90 189 -10.43 0.0011
2021-01-28 2020-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 7,734 0 0.00 211 47.55 0.0013
2020-11-06 2020-09-30 13F RETROPHIN COM 761299106 7,734 0 0.00 143 -9.49 0.0010
2020-07-28 2020-06-30 13F RETROPHIN COM 761299106 7,734 5,564 256.41 158 393.75 0.0014
2020-05-06 2020-03-31 13F RETROPHIN COM 761299106 2,170 0 0.00 32 3.23 0.0003
2020-01-21 2019-12-31 13F RETROPHIN COM 761299106 2,170 0 0.00 31 24.00 0.0002
2019-10-18 2019-09-30 13F RETROPHIN COM 761299106 2,170 0 0.00 25 -43.18 0.0002
2019-07-30 2019-06-30 13F RETROPHIN COM 761299106 2,170 0 0.00 44 -10.20 0.0004
2019-04-29 2019-03-31 13F RETROPHIN COM 761299106 2,170 -668 -23.54 49 -23.44 0.0004
2019-01-25 2018-12-31 13F RETROPHIN COM 761299106 2,838 0 0.00 64 -21.95 0.0006
2018-11-09 2018-09-30 13F RETROPHIN COM 761299106 2,838 0 0.00 82 6.49 0.0007
2018-08-06 2018-06-30 13F RETROPHIN COM 761299106 2,838 0 0.00 77 22.22 0.0007
2018-05-03 2018-03-31 13F RETROPHIN COM 761299106 2,838 0 0.00 63 5.00 0.0006
2018-01-31 2017-12-31 13F RETROPHIN COM 761299106 2,838 966 51.60 60 27.66 0.0005
2017-11-08 2017-09-30 13F RETROPHIN COM 761299106 1,872 0 0.00 47 30.56 0.0004
2017-08-08 2017-06-30 13F RETROPHIN COM 761299106 1,872 0 0.00 36 2.86 0.0004
2017-05-04 2017-03-31 13F RETROPHIN COM 761299106 1,872 0 0.00 35 0.00 0.0003
2017-02-10 2016-12-31 13F RETROPHIN COM 761299106 1,872 239 14.64 35 -5.41 0.0004
2016-11-14 2016-09-30 13F RETROPHIN COM 761299106 1,633 0 0.00 37 27.59 0.0004
2016-08-01 2016-06-30 13F RETROPHIN COM 761299106 1,633 0 0.00 29 31.82 0.0004
2016-05-13 2016-03-31 13F RETROPHIN COM 761299106 1,633 0 0.00 22 -31.25 0.0003
2016-01-29 2015-12-31 13F RETROPHIN COM 761299106 1,633 1,309 404.01 32 357.14 0.0004
2015-11-10 2015-09-30 13F RETROPHIN COM 761299106 324 324 7 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.